Information Provided By:
Fly News Breaks for July 25, 2019
Jul 25, 2019 | 06:30 EDT
JMP Securities analyst David Turkaly raised his price target on Integra LifeSciences to $75 after its Q2 earnings beat and raised FY19 guidance, saying the results position the company "ahead of schedule" in achieving its operational and financial targets. The analyst adds that Integra's completed integration of Codman by Q3-end positions the company for organic growth of at least 5% in the second half of 2019.
News For IART From the Last 2 Days
There are no results for your query IART